trending Market Intelligence /marketintelligence/en/news-insights/trending/QmrT4uTj7kM2w5aQOP957A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Zafgen appoints CEO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Zafgen appoints CEO

Zafgen Inc. named Jeffrey Hatfield as its CEO, replacing Thomas Hughes, who will remain with the company as president and assume the newly created role of chief scientific officer.

Hatfield was most recently the CEO of Vitae Pharmaceuticals.

Both executives will also join the Zafgen board.